OpenAIRE is about to release its new face with lots of new content and services.
During September, you may notice downtime in services, while some functionalities (e.g. user registration, login, validation, claiming) will be temporarily disabled.
We apologize for the inconvenience, please stay tuned!
For further information please contact helpdesk[at]openaire.eu

fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Zachariou, Margarita; Dissanayake, Dilshani; Owen, Markus; Mason, Rob; Coombes, Stephen (2006)
Publisher: Elsevier
Languages: English
Types: Article
Subjects:
Gating of sensory (e.g. auditory) information has been demonstrated as a reduction in the auditory-evoked potential responses recorded in the brain of both normal animals and human subjects. Auditory gating is perturbed in schizophrenic patients and pharmacologically by drugs such as amphetamine, phencyclidine or ketamine, which precipitate schizophrenic-like symptoms in normal subjects. The neurobiological basis underlying this sensory gating can be investigated using local field potential recordings from single electrodes. In this paper we use such technology to investigate the role of cannabinoids in sensory gating. Cannabinoids represent a fundamentally new class of retrograde messengers which are released postsynaptically and bind to presynaptic receptors. In this way they allow fine-tuning of neuronal response, and in particular can lead to so-called depolarization-induced suppression of inhibition (DSI). Our experimental results show that application of the exogenous cannabinoid WIN55, 212-2 can abolish sensory gating as measured by the amplitude of local field responses in rat hippocampal region CA3. Importantly we develop a simple firing rate population model of CA3 and show that gating is heavily dependent upon the presence of a slow inhibitory (GABAB) pathway. Moreover, a simple phenomenological model of cannabinoid dynamics underlying DSI is shown to abolish gating in a manner consistent with our experimental findings.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • [1] C. B´edard, H. Kr¨oger and A. Destexhe, Modeling Extracellular Field Potentials and the Frequency-Filtering Properties of Extracellular Space, Biophys J 86 (2004) 1829-1842.
    • [2] P. C. Bickford and K. D. Wear, Restoration of sensory gating of auditory evoked response by nicotine in fimbria-fornix lesioned rats, Brain Res 705 (1995) 235-240.
    • [3] P. C. Bickford-Wimer, H. Nagamoto, R. Johnson, L. E. Adler, M. Egan and G. M. Rose, Auditory sensory gating in hippocampal neurons: A model system in rat, Biol Phychiatry 27 (1990) 183-192.
    • [4] F. Chaperon and M. H. Thiebot, Behavioral effects of cannabinoid agents in animals, Crit Rev Neurobiol 13 (1999) 243-281.
    • [5] N. M. W. J. de Bruin, B. A. Ellenbroek, E. L. J. M. Van Luijtelaar, A. R. Cools and K. E. Stevens, Hippocampal and cortical sensory gating in rats: Effects of quinpirole microinjections in nucleus accumbens core and shell, Neuroscience 105 (2001) 169-180.
    • [6] N. M. W. J. de Bruin, E. L. J. M. Van Luijtelaar, A. R. Cools and B. A. Ellenbroek, Filtering Disturbances in Schizophrenic Patients. Gating of Auditory Evoked Potentials and Prepulse Inhibition of the Acoustic Startle Response Compared. Emphasis on the role of Dopamine, Current Neuropharmacol 1 (2003) 47-87.
    • [7] W. D. N. Dissanayake, M. Zachariou, C. A. Marsden and R. Mason, Abolition of sensory gating by the cannabinoid WIN55, 212-2 in the rat hippocampus, Psychopharmacol J 20 (2006) A45.
    • [8] H. M. Emrich, F. M. Leweke and U. Schneider. Towards a Cannabinoid Hypothesis of Schizophrenia: Cognitive Impairments Due to Dysregulation of the Endogenous Cannabinoid System, Pharmacol Biochem Behav 56 (1997) 803-807.
    • [9] K. A. Flach, L. E. Adler, G. A. Gerhardt, P. Bickford and R. J. MacGregor, Sensory gating in a computer model of the CA3 neural network of the hippocampus, Biol Psychiatry 40 (1996) 1230-1245.
    • [10] T. F. Freund, I. Katona and D. Piomelli, Role of endogenous cannabinoids in synaptic signalling, Physiol Rev 83 (2003) 1017-1066.
    • [11] K. M. Hershman, R. Freedman and P. C. Bickford, GABAB antagonists diminish the inhibitory gating of auditory response in the rat hippocampus, Neurosci Lett 190 (1995) 133-136.
    • [12] D. R. Lara, Inhibitory Deficit in Schizophrenia is Not Necessarily a GABAergic Deficit, Cell Mol Neurobiol 22 (2002) 239-247.
    • [18] H. R. Wilson and J. D. Cowan, Excitatory and Inhibitory interactions in localized populations of model neurons, Biophys J 12 (1972) 1-24,
    • [19] R. I. Wilson and R. A. Nicoll, Endocannabinoid signaling in the brain, Science 296 (2002) 678-682.
    • [20] R. I. Wilson and R. A. Nicoll, Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses, Nature 410 (2001) 1-4.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok